Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
FP01 - Early Stage/Localized Disease/Ablative Therapies
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters (Featured)
- Track: Early Stage/Localized Disease/Ablative Therapies
-
+
FP01.01 - The Association of Bevacizumab with a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505 in Completely Resected Stage IB-IIIA NSCLC
00:00 - 00:00 | Presenter: John Varlotto
- Abstract
Loading...
-
+
P62 - Screening and Early Detection - Technological Advances for Detection and Prognostication of Early-Stage Lung Cancer
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Screening and Early Detection
-
+
P62.02 - A Predictive Model to Guide Brain MRI Surveillance in Patients With Metastatic Lung Cancer: Impact on Real World Outcomes
00:00 - 00:00 | Presenter: Julie Tsu-Yu Wu
- Abstract
Loading... -
+
P62.03 - Survival After Distant Recurrent Versus De Novo Stage IV Metastatic Lung Cancer Under Low-Dose Computed Tomography Screening
00:00 - 00:00 | Presenter: Chloe Chang Su
- Abstract
Loading...
-
+
PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)
- 06:30 - 08:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
-
+
PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
07:04 - 07:14 | Presenter: Nasser Altorki
- Abstract
Loading... -
+
PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials
07:38 - 07:48 | Presenter: Matthew Smeltzer
- Abstract
Loading...
-
+
PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)
- 14:30 - 16:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
-
+
PL02A.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
15:04 - 15:14 | Presenter: Nasser Altorki
- Abstract
Loading... -
+
PL02A.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials
15:38 - 15:48 | Presenter: Matthew Smeltzer
- Abstract
Loading...
-
+
WS03 - Women in Thoracic Oncology Workshop
- 13:45 - 15:15
- 9/11/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Workshop
- Track: N.A.
- Moderators:Heather Wakelee, Clarissa Mathias, Narjust Duma, Deborah Blythe Doroshow
-
+
WS06 - Joint IASLC - CAALC - CSCO Workshop: Looking Toward the Future: Recognizing and Curing Lung Cancer
- 22:15 - 23:45
- 9/11/2021
- Location: Program Auditorium
- Not for CME Credit
- Type: Workshop
- Track: N.A.
- Moderators:Caicun Zhou, ChunXue Bai
-
+
WS06.04 - Neoadjuvant/Adjuvant Immunotherapy for Curing Non-driver Genes Resectable NSCLC
22:41 - 22:53 | Presenter: Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
GA01 - IASLC General Assembly
- 15:00 - 16:00
- 9/12/2021
- Location: Program Auditorium
- Type: Highlights
- Track: N.A.
-
+
GA01.02 - Recognition of Outgoing & Incoming IASLC Board of Directors
15:00 - 15:00 | Presenter: Tetsuya Mitsudomi, Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
GA01.07 - Wrap Up & Adjourn
15:00 - 15:00 | Presenter: Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
PL04 - Plenary 4: Stigma as Risk Factor: Why You Should Care (Japanese, Mandarin, Spanish Translation Available)
- 16:15 - 17:15
- 9/14/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:Heather Wakelee, Merel Hennink
-
+
PL04.01 - Words Matter
16:15 - 16:22 | Presenter: Jill Feldman
- Abstract
No abstract available for this presentation
-
+
PL04.02 - NLCRT Campaign to End Lung Cancer Stigma
16:22 - 16:32 | Presenter: Jamie L Studts
- Abstract
No abstract available for this presentation
-
+
PL04.03 - Talk About Solutions: Empathic Communication Module, Language Guide, Projects and Deliverables in Stigma with Attention to the Intersection of Patients, Clinicians and Researchers
16:32 - 16:42 | Presenter: Jamie Ostroff, Smita Banerjee
- Abstract
No abstract available for this presentation
-
+
PL04.04 - Psychological Distress and Stigma for People with Lung Cancer: Time to Act
16:42 - 16:47 | Presenter: Suzanne Chambers
- Abstract
Loading... -
+
PL04.05 - Stigma as Risk Factor - Why You Should Care
16:47 - 16:52 | Presenter: Kazuo Hasegawa
- Abstract
No abstract available for this presentation
-
+
PL04.06 - ‘I Didn’t Smoke’ Language and Stigma Surrounding Lung Cancer (Personal Experience)
16:52 - 16:55 | Presenter: Gina Hollenbeck
- Abstract
No abstract available for this presentation
-
+
PL04.07 - Live Discussion with Speakers
16:55 - 17:15
- Abstract
No abstract available for this presentation
